Clarus Group, Inc. Rx Sight, Inc. Transaction History
Clarus Group, Inc.
- $235 Million
- Q3 2024
A detailed history of Clarus Group, Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, Clarus Group, Inc. holds 5,000 shares of RXST stock, worth $225,250. This represents 0.1% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$225,250
Previous $300,000
17.67%
% of portfolio
0.1%
Previous 0.13%
Shares
1 transactions
Others Institutions Holding RXST
# of Institutions
225Shares Held
32.3MCall Options Held
394KPut Options Held
32K-
Ra Capital Management, L.P. Boston, MA3.92MShares$176 Million2.7% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$103 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.75MShares$78.7 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.17MShares$52.7 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.25B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...